🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine the effectiveness of rizatriptan f...
Status
Withdrawn
Location
Madigan Army Medical Center - Neurology Clinic
Start Date
2011-02
Trial ID
NCT01306266
Treatments Being Tested
A study to evaluate rizatriptan/MK0462 (5 and 10 mg) for the treatment of a...
Status
Completed
Location
Multiple Locations
Start Date
1995-03
Trial ID
NCT00897949
Treatments Being Tested
Triptans are first choice drugs in the acute treatment of migraine and clus...
Status
Completed
Location
IRCCS San Raffaele Pisana, Clinical Trial Center
Start Date
2009-07
Trial ID
NCT00753311
Treatments Being Tested
A study to provide evidence supporting the benefit of Rizatriptan in patien...
Status
Completed
Location
Multiple Locations
Start Date
2009-06-10
Trial ID
NCT00894556
Treatments Being Tested
This study will provide additional efficacy data for rizatriptan when used ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03-24
Trial ID
NCT00812006
Treatments Being Tested
The purpose of this study is to investigate the safety and tolerability of ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-21
Trial ID
NCT00443209
The purpose of this study is to determine if the addition of preventive med...
Status
Completed
Location
Ohio University
Start Date
2001-07
Trial ID
NCT00910689
This Clinical Trial evaluates the Safety and Efficacy of Rizatriptan for th...
Status
Completed
Location
Multiple Locations
Start Date
2009-11-30
Trial ID
NCT01001234
Treatments Being Tested
Suffering from dizzy spells and migraine headaches? Vestibular Migraine (V...
Status
Completed
Location
University of California, Los Angeles
Start Date
2014-12
Trial ID
NCT02447991
Treatments Being Tested
A study to compare rizatriptan (MK0462) 5 mg by mouth (p.o.) and sumatripta...
Status
Completed
Location
Multiple Locations
Start Date
1995-08
Trial ID
NCT00897104
Treatments Being Tested